Try our Advanced Search for more refined results
September 10, 2012
SARATOGA ADVANTAGE TRUST HEALTH & BIOTECHNOLOGY PORTFOLIO v. PAR PHARMACEUTICAL COMPANIES, INC. et al
Case Number:
2:12-cv-05652
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 12, 2012
TPG's $2B Par Pharma Buyout Bid Harms Investors, Suit Says
A Par Pharmaceutical Cos. Inc. shareholder launched a class action Wednesday challenging private equity firm TPG Capital's $1.9 billion bid to take the generic-drug maker private, saying the deal was based on a flawed process favoring TPG and Par.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login